NovaBay Pharmaceuticals, Inc. Gains 71.67%
Wed, Aug 20, 2025 at 07:52 PM
NovaBay Pharmaceuticals, Inc. (NBY:NYSEMKT) shot up at $1.03, a gain of 71.7%. On Wed, Aug 20, 2025, NBY:NYSEMKT hit a New 2-Week High of $1.03. The stock appeared on our News Catalysts scanner on Tue, Aug 19, 2025 at 07:54 PM in the 'AGREEMENT' category. From Wed, Aug 06, 2025, the stock recorded 60.00% Up Days and 27.27% Green Days
About NovaBay Pharmaceuticals, Inc. (NBY:NYSEMKT)
NovaBay Pharmaceuticals Inc is a biopharmaceutical company engaged in commercializing & developing non-antibiotic anti-infective products to address the unmet therapeutic needs of the eye care market. Its product categories include NEUTROX & CELLERX.
Top 10 Gainers:
- Hempacco Co., Inc. (HPCO:NASDAQ), 350%
- Tharimmune, Inc. (THAR:NASDAQ), 206.81%
- Smart for Life, Inc. (SMFL:NASDAQ), 92.31%
- NovaBay Pharmaceuticals, Inc. (NBY:NYSEMKT), 71.67%
- Alpha Technology Group Limited (ATGL:NASDAQ), 51.49%
- Shineco, Inc. (SISI:NASDAQ), 36.97%
- Pop Culture Group Co., Ltd (CPOP:NASDAQ), 36.14%
- Radiopharm Theranostics Limited (RADX:NASDAQ), 32.87%
- Rocket Pharmaceuticals, Inc. (RCKT:NASDAQ), 28.87%
- CNS Pharmaceuticals, Inc. (CNSP:NASDAQ), 28.84%